Assessment of hepatitis B immunization status after antineoplastic therapy in children with cancer.

Karaman, Serap; Vural, Sema; Yildirmak, Yildiz; Urganci, Nafiye; Usta, Merve

Karaman, Serap; Vural, Sema; Yildirmak, Yildiz; Urganci, Nafiye; Usta, Merve.

Affiliation

Karaman S; Department of Pediatric Hematology, Sisli Etfal Education and Research Hospital Clinic of Pediatrics, Istanbul, Turkey. drkaramans@yahoo.com

Ann Saudi Med ; 31(6): 573-6, 2011.

Article in En | MEDLINE | ID: mdl-22048500

Subject(s)

Antineoplastic Agents/adverse effects; Hepatitis B Antibodies/blood; Hepatitis B Vaccines/administration & dosage; Hepatitis B; Neoplasms/drug therapy; Vaccination; Adolescent; Antineoplastic Agents/administration & dosage; Child; Child, Preschool; Female; Hepatitis B/epidemiology; Hepatitis B/etiology; Hepatitis B/immunology; Hepatitis B/prevention & control; Humans; Male; Monitoring, Immunologic/methods; Neoplasms/classification; Retrospective Studies; Turkey/epidemiology; Vaccination/methods; Vaccination/statistics & numerical data

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Vaccination / Hepatitis B Vaccines / Hepatitis B / Hepatitis B Antibodies / Neoplasms / Antineoplastic Agents Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Adolescent / Child / Child, preschool / Female / Humans / Male Country/Region as subject: Asia Language: En Year: 2011 Type: Article

Fulltext

XML

PubMed Links

Search on Google